Please find enclosed press release titled "Fredun Pharmaceuticals Expands Manufacturing Base with Fifty Facility at Palghar" issued by Fredun Pharmaceuticals Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has announced the establishment of its fifth manufacturing facility in Palghar, Maharashtra. The new 40,000 sq. ft. facility, expected to be operational by October 2026, will support veterinary products, nutraceuticals, and pharmaceutical formulations. An additional 50,000 sq. ft. expansion is also planned. The company, which posted FY25 revenues of ₹456 Cr with EBITDA of ₹55 Cr and PAT of ₹21 Cr, stated the expansion will enhance production scalability to meet growing domestic and international demand. The MD commented that this aligns with their focus on building a stronger, more scalable manufacturing foundation.
This capacity expansion signals management's confidence in growing demand across key segments, potentially supporting future revenue growth. However, investors should note the facility is not yet operational and benefits will take time to materialize.